首页> 外文OA文献 >P2Y12 Inhibitor Monotherapy with Clopidogrel versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

【2h】

P2Y12 Inhibitor Monotherapy with Clopidogrel versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

机译：P2Y12抑制剂单疗法与氯吡格雷对急性冠状动脉综合征患者经皮冠状动脉介入的患者

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Po-Wei Chen; Wen-Han Feng; Ming-Yun Ho; Chun-Hung Su; Sheng-Wei Huang; Chung-Wei Cheng; Hung-I Yeh; Ching-Pei Chen; Wei-Chun Huang; Ching-Chang Fang; Hui-Wen Lin; Sheng-Hsiang Lin; I-Chang Hsieh; Yi-Heng Li;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Impact of Baseline Bleeding Risk on Efficacy and Safety of Ticagrelor versus Clopidogrel in Chinese Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention [J] . He-Yang Wang, Yi Li, Xiao-Ming Xu, 中华医学杂志（英文版） . 2018,第017期

机译：基线出血风险对经皮冠状动脉介入治疗的中国急性冠脉综合征患者替卡格雷和氯吡格雷疗效和安全性的影响
2. Association of Ticagrelor vs Clopidogrel With Major Adverse Coronary Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention [J] . Turgeon Ricky D., Koshman Sheri L., Youngson Erik, JAMA internal medicine . 2020,第3期

机译：急性冠状动脉综合征患者经皮冠状动脉介入的患者主要不良冠状动脉事件的促甲克罗米格罗
3. Ticagrelor and Eptifibatide Bolus Versus Ticagrelor and Eptifibatide Bolus With 2-Hour Infusion in High-Risk Acute Coronary Syndromes Patients Undergoing Early Percutaneous Coronary Intervention [J] . Marian Moazez J., Alli Oluseun, Al Solaiman Firas, Wiley Interdisciplinary Reviews. Developmental Biology . 2017,第6期

机译：Ticagrelor和Eptibatide推注与TicagreloLor和ePtifibatide推注，在高危冠状动脉综合征处于经过早期经皮冠状动脉干预的患者中输注2小时
4. Evaluation of Matrix Metalloproteinase-9 (MMP-9) and its tissue inhibitor of metalloproteinase-1 (Timp-1) in patients with coronary syndromes after percutaneous intervention(PCI) [C] . Revnic F., Revnic C.R., Nica A., International Congress on Coronary Artery Disease . 2011

机译：经皮干预后冠状动脉综合征患者中基质金属蛋白酶-9（MMP-9）及其组织抑制剂及其组织抑制剂（PCI）
5. The Association between Unfractionated Heparin and Bivalirudin Used during Percutaneous Coronary Intervention for Stable Angina and Acute Coronary Syndromes and the In-Hospital and Mortality Outcomes Observed across All Body Mass Index Groups [D] . Chen, Christine. 2021

机译：在所有体重指数群体中观察到稳定冠状动脉干预期间使用经皮冠状动脉介入和急性冠状动脉综合征的冠状动脉介入和医院和死亡率结果之间的联合肝素和Bivalirudin之间的关联
6. P2Y12 Inhibitor Monotherapy with Clopidogrel versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention [O] . Po-Wei Chen, Wen-Han Feng, Ming-Yun Ho, 2020

机译：经皮冠状动脉介入治疗的急性冠脉综合征患者使用氯吡格雷和替卡格雷联合P2Y12抑制剂单药治疗
7. THE EFFICACY AND SAFETY OF TICAGRELOR AS COMPARED TO CLOPIDOGREL, WITH AND WITHOUT A GLYCOPROTEIN IIB/IIIA INHIBITOR IN PATIENTS WITH ACUTE CORONARY SYNDROMES UNDERGOING PERCUTANEOUS INTERVENTION: A PLATO (STUDY OF PLATELET INHIBITION AND PATIENT OUTCOMES) ANALYSIS [O] . Bansilal Sameer, Wiviott Stephen, Becker Richard, 2013

机译：接受过定期介入治疗的急性冠状动脉综合征患者中，替加格雷的疗效和安全性与氯吡格雷相比，有或没有糖蛋白IIB / IIIA抑制剂的疗效和安全性：普拉托（血小板抑制和分析）

P2Y12 Inhibitor Monotherapy with Clopidogrel versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

著录项

相似文献

相关主题

期刊订阅